GRNDaD: big data and sickle cell disease
GRNDaD: big data and sickle cell disease
Big data are used in the pursuit of precision medicine in the general population. Applying these tools to patients with ... Read more
9 Feb 2022
•
15mins
Investigational curative gene therapy approaches to sickle cell disease
Investigational curative gene therapy approaches to sickle cell disease
Sickle cell disease (SCD) is an inherited blood condition resulting from abnormal hemoglobin production. It is one of th... Read more
26 Jan 2022
•
12mins
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
The prospect of a clinical strategy using an adeno-associated virus (AAV) vector for expression of therapeutic levels of... Read more
26 Jan 2022
•
31mins
Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding
Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding
The availability of novel nonfactor therapeutics is revolutionizing the management of hemophilia in individuals with inh... Read more
1 Oct 2021
•
17mins
Concizumab: a novel anti-TFPI therapeutic for hemophilia
Concizumab: a novel anti-TFPI therapeutic for hemophilia
Amy Shapiro discusses the recent approval of concizumab for the treatment of patients with hemophilia. This novel subcut... Read more
12 Jan 2021
•
15mins
Naive T-cell depletion in stem cell transplantation
Naive T-cell depletion in stem cell transplantation
Allogeneic hematopoietic stem cell transplantation (HCT) is curative in many patients with advanced hematopoietic malign... Read more
13 Oct 2020
•
24mins
The management of venous thromboembolism in hospitalized patients with COVID-19
The management of venous thromboembolism in hospitalized patients with COVID-19
The high incidence of thromboembolic disease, and in particular venous thromboembolism (VTE), has emerged as an importan... Read more
15 Sep 2020
•
15mins
Gene therapy for hemophilia: anticipating the unexpected
Gene therapy for hemophilia: anticipating the unexpected
The treatment of hemophilia, which has undergone many transformative changes over the past 60 years, is poised for yet a... Read more
15 Sep 2020
•
16mins
The changing landscape of anticoagulation in cancer-associated thrombosis
The changing landscape of anticoagulation in cancer-associated thrombosis
The changing landscape of anticoagulation in cancer-associated thrombosis
10 Mar 2020
•
16mins
TA-TMA: state of the art for diagnosis and treatment
TA-TMA: state of the art for diagnosis and treatment
TA-TMA: state of the art for diagnosis and treatment by Blood Advances Talks
14 Jan 2020
•
19mins